Immunai
Immunai is a New York-based immune profiling platform that combines multi-omic single-cell genomics with ML algorithms for drug development.
Business Model:
Revenue: $5M
Employees: 51-200
Rankings
Detailed Immunai Information
Geographic Data
Address: 430 E 29th Street
City: New York
State: NY
Zip: 10016
Country: US
Financial Info
Stage:
series b
Raised Last:
$215M
Raised Total:$295M
Social
Metrics
2,683,077Website Global Rank
6,221Website Monthly Traffic
Twitter Followers
Description
Immunai is a New York-based immune profiling platform that combines multi-omic single-cell genomics with ML algorithms for drug development.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2021 | Series A | 6 | $60M |
Schusterman Foundation Catalio Capital Management Dexcel Pharma Duquesne Family Office TLV Partners Viola Group Meron Capital Schusterman Foundation Duquesne Family Office Viola Group Dexcel Pharma TLV Partners Catalio Capital Management Dexcel Pharma Duquesne Family Office Schusterman Foundation |
10/2021 | Series B | 6 | $215M |
8VC Alexandria Venture Investments Koch Disruptive Technologies Piedmont Capital Investments Talos VC Meron Capital 8VC Alexandria Venture Investments Koch Disruptive Technologies Piedmont Capital Investments Talos VC |
5/2020 | Seed Round | 3 | $20M |
TLV Partners Viola Group Meron Capital TLV Partners Viola Group |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 7/2021 | Nebion | |
| 3/2021 | Dropprint Genomics |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
